View all reports
Day One Biopharmaceuticals, Inc (DAWN) stock forecast and price target
Find the latest Day One Biopharmaceuticals, Inc dawn analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.
Date Range
investment rating
report type
sector
industry
provider
DAWNDay One Biopharmaceuticals, Inc.13.88 +0.35 (+2.59%)
At close: 08:00PM
Recommendation Rating
1.9
Analyst Price Targets (8)
Current?13.88
Average?39.38
Low?24.00
High?54.00
Related Research Reports1-5 of 5 results
| Report Name | Symbols | Sector | Provider | Date | |
|---|---|---|---|---|---|
| HPK,AOUT,CRWD,BRT,FL,ADBE,DAWN,CRK,AN | Energy,Technology,Real Estate,Healthcare,Consumer Cyclical | Argus | Sep 26, 2022 | Upgrade to begin downloading full reports | |
| GEN,BRZE,BRT,CNA,SRG,PGR,DAWN,CPRX,AN,INNV | Financial Services,Technology,Real Estate,Healthcare,Consumer Cyclical | Argus | Sep 21, 2022 | Upgrade to begin downloading full reports | |
| NWL,RPRX,TMHC,SRPT,TLYS,CNA,COHR,DAWN,CPRX | Financial Services,Technology,Healthcare,Consumer Defensive,Consumer Cyclical | Argus | Sep 16, 2022 | Upgrade to begin downloading full reports | |
| NSTS,BLFY,MS,CUK,CNXC,DAWN,SNSE,CFSB | Financial Services,Technology,Healthcare,Consumer Cyclical | Argus | Jan 24, 2022 | Upgrade to begin downloading full reports | |
| LESL,GCO,PUBM,DAWN,WEX,INGN,CLNE,DIS | Communication Services,Energy,Technology,Healthcare,Consumer Cyclical | Argus | Jun 04, 2021 | Upgrade to begin downloading full reports |